CCL20 and nasopharyngeal carcinoma: In NPC, progression-stage patients showed elevated tissue expression of CCL20 (Figure 2C), and high CCL20 expression was linked to shorter PFS (Figure 2D), while high CXCL10 expression showed a trend toward association with longer PFS (Figure 2E), though this did not reach statistical significance.